Abstract: The present invention relates to a mutant 3-hydroxybutyrate dehydrogenase (3-HBDH) with improved performance relative to the wild-type 3-HBDH, a nucleic acid encoding the mutant 3-HBDH, a cell comprising the mutant 3-HBDH or the nucleic acid, a method of determining the amount or concentration of 3-hydroxybutyrate in a sample, and a device for determining the amount or concentration of 3-hydroxybutyrate in a sample.

Abstract: A method for producing a housing part of a hearing device. The housing part serves to receive electronic components of the hearing device in a housing interior. Fibers are used to build up a fiber skeleton for a wall of the housing part at least partially surrounding the housing interior. A mechanical property of the wall is varied in a predefined manner along a reference direction of the housing part by way of the fibers. The fiber skeleton is then infiltrated, at least over part of its longitudinal extent, with a matrix material. There is also described a housing part of a hearing device and a hearing device with a housing part formed with fibers.

Abstract: The present invention relates to the use of a viscose fibre for the production of a transparent cosmetic mask. The use according to the invention is characterized in that the viscose fibre is a flat fibre, the cross section of the viscose fibre has a width-to-thickness ratio of 6:1 to 30:1, and the titre of the viscose fibre ranges from 1.0 dtex to 4 dtex.

Abstract: The present disclosure relates to a mutant 3-hydroxybutyrate dehydrogenase (3-HBDH) with improved performance relative to the wild-type 3-HBDH, a nucleic acid encoding the mutant 3-HBDH, a cell having the mutant 3-HBDH or the nucleic acid, and/or a method of determining the amount or concentration of 3-hydroxybutyrate in a sample. Also disclosed is the use of the mutant 3-HBDH for determining the amount or concentration of 3-hydroxybutyrate in a sample, and a device for determining the amount or concentration of 3-hydroxybutyrate in a sample.

Abstract: A hearing aid contains a housing and, inserted in the housing, is a frame for receiving electrical or electronic assemblies. The assemblies received in the frame contains a transmitting and/or receiving unit for electro-magnetic waves. The hearing aid moreover has an antenna assigned to the transmitting and/or receiving unit, which antenna is configured as an integral part of the frame, as a stamped/bent part or as inlay part made of metal. The antenna contains two parts which are each configured as open loops with two ends, wherein the two loop-shaped parts of the antenna are electrically shorted to each other by a respective end.

Abstract: A method for producing a housing part of a hearing device. The housing part serves to receive electronic components of the hearing device in a housing interior. Fibers are used to build up a fiber skeleton for a wall of the housing part at least partially surrounding the housing interior. A mechanical property of the wall is varied in a predefined manner along a reference direction of the housing part by way of the fibers. The fiber skeleton is then infiltrated, at least over part of its longitudinal extent, with a matrix material. There is also described a housing part of a hearing device and a hearing device with a housing part formed with fibers.

Abstract: The present invention relates to a mutant 3-hydroxybutyrate dehydrogenase (3-HBDH) with improved performance relative to the wild-type 3-HBDH, a nucleic acid encoding the mutant 3-HBDH, a cell comprising the mutant 3-HBDH or the nucleic acid, a method of determining the amount or concentration of 3-hydroxybutyrate in a sample, and a device for determining the amount or concentration of 3-hydroxybutyrate in a sample.

Abstract: The present disclosure relates to a mutant 3-hydroxybutyrate dehydrogenase (3-HBDH) with improved performance relative to the wild-type 3-HBDH, a nucleic acid encoding the mutant 3-HBDH, a cell having the mutant 3-HBDH or the nucleic acid, and/or a method of determining the amount or concentration of 3-hydroxybutyrate in a sample. Also disclosed is the use of the mutant 3-HBDH for determining the amount or concentration of 3-hydroxybutyrate in a sample, and a device for determining the amount or concentration of 3-hydroxybutyrate in a sample.

Abstract: A hearing aid includes a hearing aid housing and an antenna device constructed to receive and/or transmit electromagnetic waves having a predetermined wavelength lambda. The antenna device has a frame incorporated in the hearing aid housing for holding assemblies of the hearing aid and the frame has an electrically conductive structure being an integral part of the frame. A method for producing a hearing aid includes patterning a surface of the frame, applying an electrically conductive layer to the surface of the frame and incorporating the frame into the hearing aid housing.

Abstract: A hearing aid contains a housing and, inserted in the housing, is a frame for receiving electrical or electronic assemblies. The assemblies received in the frame contains a transmitting and/or receiving unit for electro-magnetic waves. The hearing aid moreover has an antenna assigned to the transmitting and/or receiving unit, which antenna is configured as an integral part of the frame, as a stamped/bent part or as inlay part made of metal. The antenna contains two parts which are each configured as open loops with two ends, wherein the two loop- shaped parts of the antenna are electrically shorted to each other by a respective end.

Abstract: A hearing aid includes a hearing aid housing and an antenna device constructed to receive and/or transmit electromagnetic waves having a predetermined wavelength lambda. The antenna device has a frame incorporated in the hearing aid housing for holding assemblies of the hearing aid and the frame has an electrically conductive structure being an integral part of the frame. A method for producing a hearing aid includes patterning a surface of the frame, applying an electrically conductive layer to the surface of the frame and incorporating the frame into the hearing aid housing.

Abstract: A hydrophobic ABS plastics material is formed from an acrylonitrile-butadiene-styrene copolymer (ABS) plastic feed stock and a silicone additive. The hydrophobic ABS plastics material is used to produce a casing material, and also an electrical device. The hydrophobic ABS plastics material is ideally suited for protecting sensitive electronic components from moisture via a casing.

Abstract: An auditory canal insert is to be produced which can be manufactured simply and cost-effectively and which is less susceptible to dirt, especially cerumen. To this end an auditory canal insert is proposed which has an at least essentially tubular inner section, an outer section lying at least in some area against a user's auditory canal wall when the device is being worn and a filter element, especially a cerumen-protection and/or attenuation element, in which the filter element is initially manufactured as a separate component and subsequently connected by an insert molding process in one piece with the inner section. For the filter element this thus enables a broad spectrum to be covered in respect of its acoustic and mechanical filter characteristics.

Abstract: A hydrophobic ABS plastics material is formed from an acrylonitrile-butadiene-styrene copolymer (ABS) plastic feed stock and a silicone additive. The hydrophobic ABS plastics material is used to produce a casing material, and also an electrical device. The hydrophobic ABS plastics material is ideally suited for protecting sensitive electronic components from moisture via a casing.

Abstract: A hearing apparatus, more particularly a hearing aid, generally requires sound or electrical signals to be conducted from a housing, worn outside of an auditory canal of a user, to an earpiece which has been inserted into the auditory canal. An appropriate conduction device often has a soft tube. The tube must be fixedly connected to the earpiece so that the latter can be pulled out of the auditory canal using the tube. Nevertheless, the connection between the tube and the earpiece is made detachable by an appropriate plug so that the earpiece can be cleaned. The plug is attached as securely as possible to the soft tube. One end of the tube and a region of the plug may be encapsulated by a material by insert molding or the tube and the plug may be welded together. A method for producing a conduction device is also provided.

Abstract: A mutant of PQQ-dependent soluble glucose dehydrogenase (s-GDH; EC 1.1.5.2) is provided with improved specificity for glucose as compared to maltose, having a substitution of threonine at position 348 by either glycine, alamine or serine, wherein said mutant additionally comprises, at least one mutation for improving the stability of the mutant and one or more mutation(s) for improving the affinity of the mutant to glucose, and/or one or more mutation(s) for further improving the specificity of the mutant for glucose as compared to maltose, and wherein position 348 correspond to the amino acid positions known from the A. calcoaceticus s-GDH wild-type sequence. Also disclosed are genes encoding such mutant s-GDH, and different applications of these s-GDH mutants, particularly for determining the concentration of glucose in a sample.

Abstract: The present invention relates to improved variants of soluble pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenases (s-GDH), to genes encoding mutated s-GDH, to mutant proteins of s-GDH with improved substrate specificity for glucose, and to different applications of these s-GDH variants, particularly for determining concentrations of sugar, especially of glucose in a sample.

Abstract: A mutant of PQQ-dependent soluble glucose dehydrogenase (s-GDH; EC 1.1.5.2) is provided with improved specificity for glucose as compared to maltose, having a substitution of threonine at position 348 by either glycine, alamine or serine, wherein said mutant additionally comprises, at least one mutation for improving the stability of the mutant and one or more mutation(s) for improving the affinity of the mutant to glucose, and/or one or more mutation(s) for further improving the specificity of the mutant for glucose as compared to maltose, and wherein position 348 correspond to the amino acid positions known from the A. calcoaceticus s-GDH wild-type sequence. Also disclosed are genes encoding such mutant s-GDH, and different applications of these s-GDH mutants, particularly for determining the concentration of glucose in a sample.

Abstract: The present invention relates to improved variants of soluble pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenases (s-GDH), to genes encoding mutated s-GDH, to mutant proteins of s-GDH with improved substrate specificity for glucose, and to different applications of these s-GDH variants, particularly for determining concentrations of sugar, especially of glucose in a sample.

Abstract: The present invention relates to improved variants of soluble pyrroloquinoline quinone (PQQ)-dependent glucose dehydrogenases (s-GDH), to genes encoding mutated s-GDH, to mutant proteins of s-GDH with improved substrate specificity for glucose, and to different applications of these s-GDH variants, particularly for determining concentrations of sugar, especially of glucose in a sample.